Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 10/2007

01-10-2007 | Breast Oncology

Occult Breast Lesion Localization plus Sentinel Node Biopsy (SNOLL): Experience with 959 Patients at the European Institute of Oncology

Authors: Simonetta Monti, MD, Viviana Galimberti, MD, Giuseppe Trifiro, MD, Concetta De Cicco, MD, Nicolas Peradze, MD, Fabricio Brenelli, MD, Julia Fernandez-Rodriguez, MD, Nicole Rotmensz, PhD, Antuono Latronico, MD, Anastasio Berrettini, MD, Manuela Mauri, MD, Leonidas Machado, MD, Alberto Luini, MD, Giovanni Paganelli, MD

Published in: Annals of Surgical Oncology | Issue 10/2007

Login to get access

Abstract

Background

Non-palpable breast lesions are diagnosed frequently posing the problem of localization and removal. When such lesions are malignant, axillary node status must be determined. We report our experience using radio-guided occult lesion localization (ROLL) for locating and removing non-palpable breast lesions together with sentinel node biopsy (SNB) to assess axillary status. We call the technique SNOLL.

Methods

From March 1997 to April 2004, 1046 consecutive patients presented suspicious non-palpable breast lesions and were programmed for conservative surgery and SNB. In 87 patients intraoperative histological examination revealed a benign lesion and SNB was not performed. The remaining 959 patients, with cytologically or histologically proven cancer, underwent SNOLL with immobile radiotracer injected under mammographic or ultrasound (US) guidance into the lesion, and subsequent injection of mobile tracer subdermally to localize the sentinel node (SN). Patients then underwent breast surgery and SNB.

Results

Breast lesions were localized by ROLL in 99.6% of cases and were removed radically with negative margins in 91.9% of cases. Sentinel nodes were detected in all but one case. Intraoperative or definitive histological examination revealed 776 invasive/microinvasive carcinomas and 182 with in situ disease. Sentinel nodes were positive in 154 (19.8%) of 776 invasive/microinvasive cancers and in two with ductal intraepithelial neoplasia (1.1%).

Conclusions

In SNOLL the injection procedures are performed separately, but both lesion and SNs are removed together; axillary dissection is performed if the SN is positive, thus definitive treatment of malignant non-palpable lesions occurs in a single surgical session.
Literature
1.
Cady B, Stone MD, Schuler JG, et al. The new era in breast cancer. Invasion, size, and nodal involvement dramatically decreasing as a result of mammographic screening. Arch Surg 1996;131:301–8PubMed
2.
Tabar L, Fagerberg CJG, Gad A, et al. Reduction in mortality from breast cancer after mass screening with mammography. Lancet 1985;1:829–32PubMedCrossRef
3.
4.
Rampaul RS, Bagnall M, Burrell H, Pinder SE, Evans AJ, Macmillan RD. Randomized clinical trial comparing radioisotope occult lesion localization and wire-guided excision for biopsy of occult breast lesions. Br J Surg 2004;91:1575–7PubMedCrossRef
5.
Gennari R, Galimberti V, De Cicco C, et al. Use of technetium-99m-labeled colloid albumin for preoperative and intraoperative localization of nonpalpable breast lesions. J Am Coll Surgeons 2000;190:692–8CrossRef
6.
Luini A, Zurrida S, Paganelli G, et al. Comparison of radioguided excision with wire localization of occult breast lesions. Br J Surg 1999;86:522–5PubMedCrossRef
7.
Paganelli G, De Cicco C, Luini A, et al. Radioguided surgery in non-palpable breast lesions. Eur J Nucl Med 1997;24:893CrossRef
8.
Luini A, Zurrida S, Galimberti V, Paganelli G. Radioguided surgery of occult breast lesions. Eur J Cancer 1998;34:204–5PubMedCrossRef
9.
Veronesi U, Paganelli G, Galimberti V, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997;349:1864–7PubMedCrossRef
10.
Krag D, Weaver D, Ashikana T, et al. The sentinel node in breast cancer - a multicentre validation study. New Engl J Med1998;339:941–6PubMedCrossRef
11.
De Cicco C, Pizzamiglio M, Trifiro G, et al. Radioguided occult lesion localisation (ROLL) and surgical biopsy in breast cancer. Technical aspects. Q J Nucl Med 2002;46:145–51PubMed
12.
De Cicco C, Trifiro G, Intra M, et al. Optimised nuclear medicine method for tumour marking and sentinel node detection in occult primary breast lesions. Eur J Nucl Med Mol I 2004;31:349–54CrossRef
13.
Veronesi U, Paganelli G, Viale G, et al. Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study. Lancet Oncol 2006;7:983–90PubMedCrossRef
Metadata
Title
Occult Breast Lesion Localization plus Sentinel Node Biopsy (SNOLL): Experience with 959 Patients at the European Institute of Oncology
Authors
Simonetta Monti, MD
Viviana Galimberti, MD
Giuseppe Trifiro, MD
Concetta De Cicco, MD
Nicolas Peradze, MD
Fabricio Brenelli, MD
Julia Fernandez-Rodriguez, MD
Nicole Rotmensz, PhD
Antuono Latronico, MD
Anastasio Berrettini, MD
Manuela Mauri, MD
Leonidas Machado, MD
Alberto Luini, MD
Giovanni Paganelli, MD
Publication date
01-10-2007
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 10/2007
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-007-9452-2

Other articles of this Issue 10/2007

Annals of Surgical Oncology 10/2007 Go to the issue

Editorial

Pulmonary Metastasectomy for Melanoma: Beyond the Standard of Care

Breast Oncology

Mechanisms of HER2-Induced Endothelial Cell Retraction

OriginalPaper

Telomerase Activity in Giant Cell Tumors of Bone

Melanomas

Stage-IV Melanoma and Pulmonary Metastases: Factors Predictive of Survival

Endocrine Tumors

Anaplastic Carcinoma of the Thyroid Arising More Often from Follicular Carcinoma than Papillary Carcinoma

Breast Oncology

Internal Mammary Nodal Chain Drainage Is a Prognostic Indicator in Axillary Node-Positive Breast Cancer